|
|
|
|
: ڱ ƾ䡱'ḷ' ڷγ19 ־ |
ḷ ڷγ19 ϳCDC, ֿ Ρ ൿ ؾߡAAO, ḷ ɼSARS-CoV-2 ڷγ̷ (ڷγ19) Ű ̷̴. ڷγ19 ڵ پ ϰ ִ , ڷγ19 ũ (Pink Eye) Ҹ ḷ(Infective Conjunctivitis) Ÿ ִٴ Դ. 2020 216 ڷγ19 23%Լ ḷ Ȯߴ. , 1~3%Լ Ÿ ġ ˷ ̿Լ ɼ ٴ ߰ߴ. ḷ ܿ ڷγ19 ٸ Ȱ ų , ̴ ÷ Ǵ پ ִ.
ڷγ19 Ȱ 20201 翡 ڷγ19 ġ Ȱ 2~32% Ѵ. ḷ Ȱ ϳ ó 幰, ڷγ19 ȯڿ ϰ ϴ Ÿ. ḷ :- , - , - , - ν- ̹ ḷ ܿ ýŰ, , ٸ Ÿ ִ. ڷγ19 ִ ٸ Ȱ :- (Episcleritis): ḷ ȫ Ÿ ȯ- ȭ(Retinal Change): , Ż ȭ- ýŰ濰(Optic Neuritis): ýŰ ÷ þ ̻ ʷǴ ȯ ڷγ19 ڷγ19 ϴ ̷ ڷγ ̷ 迭 Ͽ SARS-CoV-2̴. ڷγ ̷ ΰԵ ˹߽ų ִ. ̷ ִ. 2021 ڷγ19 ֿ ̴. ɼ ؼ ڷγ19 ֱ ϴ ƾ Ѵ١ ǰѴ. ڷγ19κ ȣϴ ̱ 漾(CDC) վı ߿伺 ϸ, , , ൿ ؾ Ѵٰ Ѵ. Ư Ƿ ũ ȣ ǰѴ. ̱Ȱȸ(AAOAmerican Academy of Ophthalmology) ḷ ڷγ19 ̷ ɼ ִ١ ǥߴ. ḷ ü ڷγ19 . SARS-CoV-2 ḷ η ۿ ڷγ19 ̾ ִ.
|
|
|
|
|
|
|
|